{"public_id":"co_4948f18c289c2266133a04ad7e2a3d6d","status":"active","merged_into_public_id":null,"resolved_public_id":"co_4948f18c289c2266133a04ad7e2a3d6d","name":"prostate-specific antigen","description":"A biomarker used as one independently reported outcome measure in prostate cancer clinical trials.","aliases":["PSA"],"types":["biomarker","outcome measure"],"contributors":[{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["extraction"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":35,"public_id":"b2adb6bfad","public_label":"Anonymous (b2adb6bfad)","roles":["review"],"url":"https://sah.borca.ai/u/b2adb6bfad"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":9449984,"title":"Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.","citation_count":2187,"url":"https://sah.borca.ai/papers/9449984"}],"claims":[{"public_id":"cl_df5b0f9c200a1ad5d4b8fb484c271e5f","text":"Outcomes in prostate cancer trials should be reported independently for PSA, imaging, and clinical measures, avoiding grouped categorizations such as complete or partial response.","corpus_id":9449984,"url":"https://sah.borca.ai/claims/cl_df5b0f9c200a1ad5d4b8fb484c271e5f"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_4948f18c289c2266133a04ad7e2a3d6d","url":"https://sah.borca.ai/concepts/co_4948f18c289c2266133a04ad7e2a3d6d"}